The biology of hormone refractory prostate cancer: Why does it develop?

Urologic Clinics of North America

Volumn 26, Issue 2, 1999, Pages 263-273

  Isaacs, J T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANDROGEN; GLUTATHIONE TRANSFERASE; PROTEIN BCL 2;

ANDROGEN THERAPY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ORCHIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0032933296     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70066-5     Document Type: Article

References (38)

1. C.W. Bayne F. Donnelly K. Chapman A novel coculture model for benign prostatic hyperplasia expressing both isoforms of 5α-reductase J Clin Endocrinol Metab 83 1998 206
2. R.R. Berges J. Vukanovic J.I. Epstein Implication of the cell kinetic changes during the progression of human prostatic cancer Clin Cancer Res 1 1995 473
3. H. Bonkhoff K. Remberger Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth–a stem cell model Prostate 28 1996 98
4. H. Bonkhoff U. Stein K. Remberger The proliferative function of basal cells in the normal and hyperplastic human prostate Prostate 24 1994 114
5. S. Chen C.S. Song Y. Lavrovsky Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme Mol Endocrinol 12 1998 1558
6. C.S. Choong M.J. Sturm J.A. Strophair Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly—Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels J Clin Endocrin Metab 81 1996 236
7. M. Colombel F. Symmans S. Gil Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers Am J Pathol 143 1993 390
8. Z. Culig A. Hobisch M.V. Cronauer Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone Mol Endocrinol 7 1993 1541
9. Z. Culig A. Hobisch M.V. Cronauer Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor Cancer Res 54 1994 5474
10. G.R. Cunha B. Lung The possible influences of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (tfm) mice J Exp Zool 205 1978 342
11. G.R. Cunha L.W.K. Chung J.M. Shannon Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interactions Rec Prog Horm Res 39 1983 559
12. S.R. Denmeade X.D. Lin J.T. Isaacs Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer Prostate 28 1996 251
13. M.A. Eisenberger B.A. Blumenstein E.D. Crawford Bilateral orchiectomy with or without flutamide for metastatic prostate cancer N Engl J Med 339 1998 1036
14. J.J. Freed S.A. Schatz Chromosomal aberrations in cultured cells deprived of single essential amino acids Exp Cell Res 55 1969 393
15. Y. Furuya S. Krajewski J.I. Septein Expression of bcl-2 and the progression of human and rodent prostatic cancers Clin Cancer Res 2 1996 389
16. J. Gao J.T. Isaacs Development of an androgen receptor null model for identifying the site of initiation for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells Cancer Res 58 1998 3299
17. E.S. Grant K.W. Batchelor F.K. Habib The androgen-independence of primary epithelial cell cultures of the prostate is associated with a down-regulation of androgen receptor gene expression Prostate 29 1996 339
18. A. Hobisch Z. Culig C. Radmayr Distant metastases from prostate carcinoma express androgen receptor protein Cancer Res 55 1995 3068
19. A. Hobisch Z. Culig C. Radmayr Androgen receptor status of lymph node metastases from prostate cancer Prostate 28 1996 129
20. D.M. Hockenbery The bcl-2 oncogene and apoptosis Semin Immunol 4 1992 413
21. J.T. Isaacs Control of cell proliferation and cell death in the normal and neoplastic prostate: A stem cell model Rogers C.H. Coffey D.S. Cunha G. Benign Prostatic Hyperplasia, Report No. INH 87-2881 1987 Department of Health and Human Services, National Institutes of Health Bethesda, MD 85
22. J.T. Isaacs Role of androgens in prostatic cancer Vitam Horm 49 1994 433
23. J.T. Isaacs D.S. Coffey Adaptation vs selection as the mechanism responsible for the relapse of prostatic cancer to androgen therapy as studied in the Dunning R-3327-H adenocarcinoma Cancer Res 41 1981 5070
24. J.T. Isaacs D.S. Coffey Etiology of BPH The Prostate Supplement 2 1989 33
25. J.T. Isaacs N. Wake D.S. Coffey Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system Cancer Res 42 1982 2353
26. I.B.J.K. Joseph J.T. Isaacs Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen responsive prostatic cancers Cancer Res 57 1997 1054
27. I.B.J.K. Joseph J.B. Nelson S.R. Denmeade Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue Clin Cancer Res 3 1997 2507
28. P. Koivisto J. Kononen C. Palmberg Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Res 57 1997 314
29. S.H. Landis T. Murray S. Bolden Cancer statistics, 1998 CA Cancer J Clin 48 1998 6
30. W.H. Lee R.A. Morton J.I. Epstein Cytidine methylation of regulatory sequences near the p-class glutahione-S-transferase gene accompanies human prostate cancer carcinogenesis Proc Natl Acad Sci USA 91 1994 11733
31. McDonnell TJ, Troncoso P, Brisbay SM, et al: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940.
32. L.V. Nazareth N.L. Weigel Activation of the human androgen receptor through a protein kinase A signaling pathway J Biol Chem 271 1996 19900
33. A.J. Raffo H. Perlman M.W. Chen Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo Cancer Res 55 1995 4438
34. E.J. Robinson D.E. Neal A.T. Collins Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium Prostate 37 1998 149
35. W.D. Tilley G. Buchana T.T. Hickey Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independent Clin Cancer Res 2 1996 277
36. A.P.M. Verhagen T.W. Aadlers F.C.S. Ramaeker Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration Prostate 13 1988 25
37. T. Viskorpi E. Hyytinen P. Koivisto In vivo amplification of the androgen receptor gene and progression of human prostate cancer Nat Genet 9 1995 401
38. J. Xu Y. Qin F.J. DeMayo Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene Science 279 1998 1922